Status:
UNKNOWN
Comparison of EUS-FNB Biopsy Techniques of Solid Pancreatic Lesions
Lead Sponsor:
Hospital Universitario Dr. Jose E. Gonzalez
Conditions:
Pancreatic Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients with a diagnosis of solid pancreatic lesions evidenced by imaging studies (CT, MRI) and who undergo endoscopic ultrasound-guided biopsy will be selected. Biopsies will be taken using modified...
Detailed Description
EUS-BAAF procedure The procedure will be performed with a linear echoendoscope (PENTAX 3.8 EG-3870 UTK) and a HITACHI HI VISION Avius ultrasound processor, after deep sedation by the anesthesiology se...
Eligibility Criteria
Inclusion
- Over 18 years old
- Any gender.
- Patients with solid pancreatic lesions evidenced by CT or MRI who do not have a histopathological diagnosis.
Exclusion
- That no lesion in the pancreas is identified by EUS.
- Pancreatic lesions with a cystic component.
- Alteration of coagulation parameters (INR\> 1.5, Platelets \<50,000 / mm3) or having taken antiplatelet agents or oral anticoagulants one week prior to the biopsy.
- History of acute pancreatitis in the last 4 weeks.
- Pregnant
- Refusal or inability to sign informed consent
Key Trial Info
Start Date :
January 8 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 30 2021
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04843956
Start Date
January 8 2020
End Date
April 30 2021
Last Update
April 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Héctor Miguel Delgado Cortes
Monterrey, Nuevo León, Mexico, 64460